nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—Blood in stool—Delavirdine—acquired immunodeficiency syndrome	0.0395	0.0644	CcSEcCtD
Bisacodyl—GPR55—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.0377	0.111	CbGpPWpGaD
Bisacodyl—GPR55—blood—acquired immunodeficiency syndrome	0.0297	0.625	CbGeAlD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0232	0.0683	CbGpPWpGaD
Bisacodyl—GPR55—lymph node—acquired immunodeficiency syndrome	0.0178	0.375	CbGeAlD
Bisacodyl—GPR55—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0176	0.052	CbGpPWpGaD
Bisacodyl—Haematochezia—Delavirdine—acquired immunodeficiency syndrome	0.0161	0.0262	CcSEcCtD
Bisacodyl—Haematochezia—Saquinavir—acquired immunodeficiency syndrome	0.0143	0.0233	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.014	0.0414	CbGpPWpGaD
Bisacodyl—GPR55—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.0136	0.04	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0127	0.0374	CbGpPWpGaD
Bisacodyl—Abdominal cramps—Zidovudine—acquired immunodeficiency syndrome	0.0114	0.0186	CcSEcCtD
Bisacodyl—Anorectal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.011	0.0179	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.0107	0.0315	CbGpPWpGaD
Bisacodyl—Anorectal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.0105	0.0172	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00986	0.0291	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00966	0.0285	CbGpPWpGaD
Bisacodyl—Abdominal cramps—Delavirdine—acquired immunodeficiency syndrome	0.00959	0.0156	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00927	0.0273	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00927	0.0273	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00905	0.0267	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00867	0.0255	CbGpPWpGaD
Bisacodyl—Abdominal cramps—Lamivudine—acquired immunodeficiency syndrome	0.00815	0.0133	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00784	0.0231	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00737	0.0217	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00737	0.0217	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00705	0.0208	CbGpPWpGaD
Bisacodyl—Abdominal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00674	0.011	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.0066	0.0195	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00635	0.0187	CbGpPWpGaD
Bisacodyl—Colitis—Delavirdine—acquired immunodeficiency syndrome	0.00622	0.0101	CcSEcCtD
Bisacodyl—Dehydration—Nelfinavir—acquired immunodeficiency syndrome	0.006	0.00979	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00597	0.0176	CbGpPWpGaD
Bisacodyl—Cramp muscle—Nelfinavir—acquired immunodeficiency syndrome	0.00581	0.00948	CcSEcCtD
Bisacodyl—Colitis—Ritonavir—acquired immunodeficiency syndrome	0.00575	0.00938	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00561	0.0165	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00561	0.0165	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00561	0.0165	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00548	0.0162	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00535	0.0158	CbGpPWpGaD
Bisacodyl—Abdominal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00525	0.00856	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00505	0.0149	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00496	0.0146	CbGpPWpGaD
Bisacodyl—Malnutrition—Amprenavir—acquired immunodeficiency syndrome	0.0049	0.00798	CcSEcCtD
Bisacodyl—Cramp muscle—Indinavir—acquired immunodeficiency syndrome	0.00468	0.00764	CcSEcCtD
Bisacodyl—Angioedema—Amprenavir—acquired immunodeficiency syndrome	0.00447	0.0073	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00427	0.0126	CbGpPWpGaD
Bisacodyl—Cramp muscle—Delavirdine—acquired immunodeficiency syndrome	0.00423	0.0069	CcSEcCtD
Bisacodyl—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00416	0.00679	CcSEcCtD
Bisacodyl—Dehydration—Ritonavir—acquired immunodeficiency syndrome	0.00404	0.00659	CcSEcCtD
Bisacodyl—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00403	0.00658	CcSEcCtD
Bisacodyl—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.00396	0.00646	CcSEcCtD
Bisacodyl—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.00392	0.00639	CcSEcCtD
Bisacodyl—Cramp muscle—Ritonavir—acquired immunodeficiency syndrome	0.00392	0.00638	CcSEcCtD
Bisacodyl—Dehydration—Saquinavir—acquired immunodeficiency syndrome	0.00389	0.00635	CcSEcCtD
Bisacodyl—Malnutrition—Nelfinavir—acquired immunodeficiency syndrome	0.00389	0.00634	CcSEcCtD
Bisacodyl—Malnutrition—Stavudine—acquired immunodeficiency syndrome	0.00387	0.00632	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00385	0.0113	CbGpPWpGaD
Bisacodyl—Malnutrition—Abacavir—acquired immunodeficiency syndrome	0.00382	0.00622	CcSEcCtD
Bisacodyl—Cramp muscle—Saquinavir—acquired immunodeficiency syndrome	0.00377	0.00615	CcSEcCtD
Bisacodyl—Muscle spasms—Nelfinavir—acquired immunodeficiency syndrome	0.00374	0.00609	CcSEcCtD
Bisacodyl—Dehydration—Lamivudine—acquired immunodeficiency syndrome	0.00371	0.00605	CcSEcCtD
Bisacodyl—Angioedema—Nevirapine—acquired immunodeficiency syndrome	0.00367	0.00598	CcSEcCtD
Bisacodyl—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00364	0.00594	CcSEcCtD
Bisacodyl—Cramp muscle—Lamivudine—acquired immunodeficiency syndrome	0.00359	0.00586	CcSEcCtD
Bisacodyl—Abdominal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00347	0.00565	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00345	0.00563	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00339	0.00998	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00337	0.00994	CbGpPWpGaD
Bisacodyl—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.00337	0.00549	CcSEcCtD
Bisacodyl—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00331	0.00539	CcSEcCtD
Bisacodyl—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00328	0.00534	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00327	0.00533	CcSEcCtD
Bisacodyl—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.00325	0.0053	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00324	0.00955	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00324	0.00955	CbGpPWpGaD
Bisacodyl—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.00324	0.00528	CcSEcCtD
Bisacodyl—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00321	0.00524	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00317	0.00935	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00317	0.00935	CbGpPWpGaD
Bisacodyl—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00316	0.00515	CcSEcCtD
Bisacodyl—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.00313	0.00511	CcSEcCtD
Bisacodyl—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00312	0.00508	CcSEcCtD
Bisacodyl—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.0031	0.00506	CcSEcCtD
Bisacodyl—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.00308	0.00502	CcSEcCtD
Bisacodyl—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00307	0.00501	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00306	0.00903	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00306	0.00498	CcSEcCtD
Bisacodyl—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.00302	0.00493	CcSEcCtD
Bisacodyl—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.00301	0.00491	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00298	0.00486	CcSEcCtD
Bisacodyl—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.00296	0.00483	CcSEcCtD
Bisacodyl—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.00296	0.00483	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00293	0.00863	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00288	0.00849	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00288	0.00849	CbGpPWpGaD
Bisacodyl—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00288	0.0047	CcSEcCtD
Bisacodyl—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.00286	0.00467	CcSEcCtD
Bisacodyl—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.00283	0.00462	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00283	0.00461	CcSEcCtD
Bisacodyl—Syncope—Indinavir—acquired immunodeficiency syndrome	0.00281	0.00458	CcSEcCtD
Bisacodyl—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.00275	0.00449	CcSEcCtD
Bisacodyl—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00275	0.00448	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00274	0.00447	CcSEcCtD
Bisacodyl—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00273	0.00446	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00273	0.00445	CcSEcCtD
Bisacodyl—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.00272	0.00444	CcSEcCtD
Bisacodyl—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00272	0.00443	CcSEcCtD
Bisacodyl—Shock—Zidovudine—acquired immunodeficiency syndrome	0.0027	0.00441	CcSEcCtD
Bisacodyl—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.0027	0.00441	CcSEcCtD
Bisacodyl—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.0027	0.0044	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00269	0.00439	CcSEcCtD
Bisacodyl—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00268	0.00438	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00268	0.00437	CcSEcCtD
Bisacodyl—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.00265	0.00433	CcSEcCtD
Bisacodyl—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00262	0.00427	CcSEcCtD
Bisacodyl—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00261	0.00426	CcSEcCtD
Bisacodyl—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.0026	0.00424	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00259	0.00423	CcSEcCtD
Bisacodyl—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00259	0.00422	CcSEcCtD
Bisacodyl—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00259	0.00422	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00259	0.00422	CcSEcCtD
Bisacodyl—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00256	0.00417	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00255	0.00415	CcSEcCtD
Bisacodyl—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00254	0.00414	CcSEcCtD
Bisacodyl—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00254	0.00414	CcSEcCtD
Bisacodyl—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00252	0.00411	CcSEcCtD
Bisacodyl—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00252	0.00411	CcSEcCtD
Bisacodyl—Shock—Indinavir—acquired immunodeficiency syndrome	0.00251	0.0041	CcSEcCtD
Bisacodyl—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00251	0.00409	CcSEcCtD
Bisacodyl—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00251	0.00409	CcSEcCtD
Bisacodyl—Headache—Amprenavir—acquired immunodeficiency syndrome	0.0025	0.00408	CcSEcCtD
Bisacodyl—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.0025	0.00408	CcSEcCtD
Bisacodyl—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00249	0.00407	CcSEcCtD
Bisacodyl—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00249	0.00406	CcSEcCtD
Bisacodyl—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00249	0.00406	CcSEcCtD
Bisacodyl—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00246	0.00402	CcSEcCtD
Bisacodyl—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00242	0.00395	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00241	0.00711	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00241	0.00394	CcSEcCtD
Bisacodyl—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.0024	0.00392	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00238	0.00701	CbGpPWpGaD
Bisacodyl—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00238	0.00387	CcSEcCtD
Bisacodyl—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00237	0.00387	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00237	0.00387	CcSEcCtD
Bisacodyl—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00237	0.00386	CcSEcCtD
Bisacodyl—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00235	0.00383	CcSEcCtD
Bisacodyl—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00234	0.00381	CcSEcCtD
Bisacodyl—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00233	0.0038	CcSEcCtD
Bisacodyl—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00232	0.00378	CcSEcCtD
Bisacodyl—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00231	0.00377	CcSEcCtD
Bisacodyl—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.0023	0.00375	CcSEcCtD
Bisacodyl—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.0023	0.00374	CcSEcCtD
Bisacodyl—Headache—Didanosine—acquired immunodeficiency syndrome	0.00228	0.00372	CcSEcCtD
Bisacodyl—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00227	0.00371	CcSEcCtD
Bisacodyl—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00226	0.00369	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00225	0.00367	CcSEcCtD
Bisacodyl—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00224	0.00365	CcSEcCtD
Bisacodyl—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00221	0.00361	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00221	0.0036	CcSEcCtD
Bisacodyl—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.0022	0.00358	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00219	0.00646	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00217	0.00641	CbGpPWpGaD
Bisacodyl—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00217	0.00354	CcSEcCtD
Bisacodyl—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00217	0.00354	CcSEcCtD
Bisacodyl—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00216	0.00353	CcSEcCtD
Bisacodyl—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00216	0.00353	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00216	0.00636	CbGpPWpGaD
Bisacodyl—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00216	0.00352	CcSEcCtD
Bisacodyl—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00213	0.00348	CcSEcCtD
Bisacodyl—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00211	0.00345	CcSEcCtD
Bisacodyl—Shock—Ritonavir—acquired immunodeficiency syndrome	0.0021	0.00343	CcSEcCtD
Bisacodyl—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.0021	0.00342	CcSEcCtD
Bisacodyl—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.0021	0.00342	CcSEcCtD
Bisacodyl—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00209	0.00341	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00209	0.00341	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00209	0.0034	CcSEcCtD
Bisacodyl—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00208	0.0034	CcSEcCtD
Bisacodyl—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00206	0.00336	CcSEcCtD
Bisacodyl—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00205	0.00335	CcSEcCtD
Bisacodyl—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00202	0.0033	CcSEcCtD
Bisacodyl—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00202	0.0033	CcSEcCtD
Bisacodyl—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00202	0.00329	CcSEcCtD
Bisacodyl—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00202	0.00329	CcSEcCtD
Bisacodyl—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00201	0.00328	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.002	0.0059	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00199	0.00325	CcSEcCtD
Bisacodyl—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00199	0.00324	CcSEcCtD
Bisacodyl—Headache—Stavudine—acquired immunodeficiency syndrome	0.00198	0.00323	CcSEcCtD
Bisacodyl—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00198	0.00323	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00197	0.00322	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00197	0.00582	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00196	0.0032	CcSEcCtD
Bisacodyl—Headache—Abacavir—acquired immunodeficiency syndrome	0.00195	0.00318	CcSEcCtD
Bisacodyl—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00195	0.00317	CcSEcCtD
Bisacodyl—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00193	0.00315	CcSEcCtD
Bisacodyl—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00192	0.00314	CcSEcCtD
Bisacodyl—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00191	0.00311	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00189	0.00308	CcSEcCtD
Bisacodyl—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00188	0.00307	CcSEcCtD
Bisacodyl—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00188	0.00307	CcSEcCtD
Bisacodyl—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00188	0.00307	CcSEcCtD
Bisacodyl—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00188	0.00306	CcSEcCtD
Bisacodyl—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00185	0.00302	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00184	0.00301	CcSEcCtD
Bisacodyl—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00183	0.00298	CcSEcCtD
Bisacodyl—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00182	0.00296	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00181	0.00533	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00178	0.0029	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00178	0.0029	CcSEcCtD
Bisacodyl—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00175	0.00285	CcSEcCtD
Bisacodyl—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00175	0.00285	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00175	0.00285	CcSEcCtD
Bisacodyl—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00172	0.00281	CcSEcCtD
Bisacodyl—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.0017	0.00278	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.0017	0.00501	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.0017	0.00501	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00169	0.00276	CcSEcCtD
Bisacodyl—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00169	0.00276	CcSEcCtD
Bisacodyl—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00169	0.00275	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00168	0.00274	CcSEcCtD
Bisacodyl—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00165	0.00269	CcSEcCtD
Bisacodyl—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00163	0.00266	CcSEcCtD
Bisacodyl—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00163	0.00265	CcSEcCtD
Bisacodyl—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00163	0.00265	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.0016	0.00262	CcSEcCtD
Bisacodyl—Headache—Indinavir—acquired immunodeficiency syndrome	0.0016	0.00261	CcSEcCtD
Bisacodyl—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.0016	0.0026	CcSEcCtD
Bisacodyl—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00158	0.00258	CcSEcCtD
Bisacodyl—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00157	0.00257	CcSEcCtD
Bisacodyl—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00155	0.00253	CcSEcCtD
Bisacodyl—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.0025	CcSEcCtD
Bisacodyl—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00153	0.00249	CcSEcCtD
Bisacodyl—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00152	0.00248	CcSEcCtD
Bisacodyl—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00152	0.00247	CcSEcCtD
Bisacodyl—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.00247	CcSEcCtD
Bisacodyl—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00147	0.0024	CcSEcCtD
Bisacodyl—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00146	0.00238	CcSEcCtD
Bisacodyl—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00145	0.00236	CcSEcCtD
Bisacodyl—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00145	0.00236	CcSEcCtD
Bisacodyl—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00143	0.00234	CcSEcCtD
Bisacodyl—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.0023	CcSEcCtD
Bisacodyl—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.00229	CcSEcCtD
Bisacodyl—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00137	0.00224	CcSEcCtD
Bisacodyl—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.00222	CcSEcCtD
Bisacodyl—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.00222	CcSEcCtD
Bisacodyl—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00134	0.00219	CcSEcCtD
Bisacodyl—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.00218	CcSEcCtD
Bisacodyl—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.00213	CcSEcCtD
Bisacodyl—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.00212	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00129	0.00381	CbGpPWpGaD
Bisacodyl—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00129	0.0021	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00128	0.00376	CbGpPWpGaD
Bisacodyl—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00207	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00126	0.0037	CbGpPWpGaD
Bisacodyl—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00203	CcSEcCtD
Bisacodyl—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.002	CcSEcCtD
Bisacodyl—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00199	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00117	0.00344	CbGpPWpGaD
Bisacodyl—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00117	0.0019	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00114	0.00336	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000674	0.00199	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000671	0.00198	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000396	0.00117	CbGpPWpGaD
